Channelopathy pathogenesis in autism spectrum disorders
- PMID:24204377
- PMCID: PMC3817418
- DOI: 10.3389/fgene.2013.00222
Channelopathy pathogenesis in autism spectrum disorders
Abstract
Autism spectrum disorder (ASD) is a syndrome that affects normal brain development and is characterized by impaired social interaction as well as verbal and non-verbal communication and by repetitive, stereotypic behavior. ASD is a complex disorder arising from a combination of multiple genetic and environmental factors that are independent from racial, ethnic and socioeconomical status. The high heritability of ASD suggests a strong genetic basis for the disorder. Furthermore, a mounting body of evidence implies a role of various ion channel gene defects (channelopathies) in the pathogenesis of autism. Indeed, recent genome-wide association, and whole exome- and whole-genome resequencing studies linked polymorphisms and rare variants in calcium, sodium and potassium channels and their subunits with susceptibility to ASD, much as they do with bipolar disorder, schizophrenia and other neuropsychiatric disorders. Moreover, animal models with these genetic variations recapitulate endophenotypes considered to be correlates of autistic behavior seen in patients. An ion flux across the membrane regulates a variety of cell functions, from generation of action potentials to gene expression and cell morphology, thus it is not surprising that channelopathies have profound effects on brain functions. In the present work, we summarize existing evidence for the role of ion channel gene defects in the pathogenesis of autism with a focus on calcium signaling and its downstream effects.
Keywords: Angelman syndrome; Fragile X syndrome; Prader-Willi syndrome; Rett syndrome; calcium; mTOR; tuberous sclerosis.
Figures
Similar articles
- The genetics of autism.Muhle R, Trentacoste SV, Rapin I.Muhle R, et al.Pediatrics. 2004 May;113(5):e472-86. doi: 10.1542/peds.113.5.e472.Pediatrics. 2004.PMID:15121991Review.
- Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder.Guglielmi L, Servettini I, Caramia M, Catacuzzeno L, Franciolini F, D'Adamo MC, Pessia M.Guglielmi L, et al.Front Cell Neurosci. 2015 Mar 2;9:34. doi: 10.3389/fncel.2015.00034. eCollection 2015.Front Cell Neurosci. 2015.PMID:25784856Free PMC article.Review.
- Ionic Channels as Potential Targets for the Treatment of Autism Spectrum Disorder: A Review.da Silva PR, do Nascimento Gonzaga TKS, Maia RE, da Silva BA.da Silva PR, et al.Curr Neuropharmacol. 2022;20(10):1834-1849. doi: 10.2174/1570159X19666210809102547.Curr Neuropharmacol. 2022.PMID:34370640Free PMC article.Review.
- Association Study of Sequence Variants in Voltage-gated Ca2+ Channel Subunit Alpha-1C and Autism Spectrum Disorders.Sayad A, Ghafouri-Fard S, Noroozi R, Omrani MD, Ganji M, Dastmalchi R, Glassy M, Taheri M.Sayad A, et al.Rep Biochem Mol Biol. 2019 Apr;8(1):56-62.Rep Biochem Mol Biol. 2019.PMID:31334289Free PMC article.
- Autism spectrum disorders: the quest for genetic syndromes.Zafeiriou DI, Ververi A, Dafoulis V, Kalyva E, Vargiami E.Zafeiriou DI, et al.Am J Med Genet B Neuropsychiatr Genet. 2013 Jun;162B(4):327-66. doi: 10.1002/ajmg.b.32152. Epub 2013 May 3.Am J Med Genet B Neuropsychiatr Genet. 2013.PMID:23650212Review.
Cited by
- Lipophilic compounds restore function to neurodevelopmental-associated KCNQ3 mutations.Edmond MA, Hinojo-Perez A, Efrem M, Yi-Chun L, Shams I, Hayoz S, de la Cruz A, Perez Rodriguez ME, Diaz-Solares M, Dykxhoorn DM, Luo YL, Barro-Soria R.Edmond MA, et al.Commun Biol. 2024 Sep 19;7(1):1181. doi: 10.1038/s42003-024-06873-4.Commun Biol. 2024.PMID:39300259Free PMC article.
- Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies.Yenkoyan K, Ounanian Z, Mirumyan M, Hayrapetyan L, Zakaryan N, Sahakyan R, Bjørklund G.Yenkoyan K, et al.Curr Med Chem. 2024;31(12):1485-1511. doi: 10.2174/0109298673252910230920151332.Curr Med Chem. 2024.PMID:37888815Free PMC article.Review.
- Motor cortex excitability and inhibitory imbalance in autism spectrum disorder assessed with transcranial magnetic stimulation: a systematic review.Masuda F, Nakajima S, Miyazaki T, Yoshida K, Tsugawa S, Wada M, Ogyu K, Croarkin PE, Blumberger DM, Daskalakis ZJ, Mimura M, Noda Y.Masuda F, et al.Transl Psychiatry. 2019 Mar 7;9(1):110. doi: 10.1038/s41398-019-0444-3.Transl Psychiatry. 2019.PMID:30846682Free PMC article.
- Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: the case of synapsins.Giovedí S, Corradi A, Fassio A, Benfenati F.Giovedí S, et al.Front Pediatr. 2014 Sep 4;2:94. doi: 10.3389/fped.2014.00094. eCollection 2014.Front Pediatr. 2014.PMID:25237665Free PMC article.Review.
- Voltage control of Ca²⁺ permeation through N-type calcium (Ca(V)2.2) channels.Buraei Z, Liang H, Elmslie KS.Buraei Z, et al.J Gen Physiol. 2014 Sep;144(3):207-20. doi: 10.1085/jgp.201411201. Epub 2014 Aug 11.J Gen Physiol. 2014.PMID:25114024Free PMC article.
References
- Adams C. E., Yonchek J. C., Schulz K. M., Graw S. L., Stitzel J., Teschke P. U., et al. (2012). Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases. Neuroscience 207 274–28210.1016/j.neuroscience.2012.01.033 - DOI - PMC - PubMed
- Antzelevitch C., Pollevick G. D., Cordeiro J. M., Casis O., Sanguinetti M. C., Aizawa Y., et al. (2007). Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115 442–44910.1161/CIRCULATIONAHA.106.668392 - DOI - PMC - PubMed
Publication types
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous